Dr. Ragisha Gopalakrishnan
Claim this profileMount Sinai Medical Center
Area of expertise
Breast Cancer
Ragisha Gopalakrishnan has run 4 trials for Breast Cancer. Some of their research focus areas include:
Colorectal Cancer
Ragisha Gopalakrishnan has run 1 trial for Colorectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mount Sinai Medical Center
Mount Sinai Comprehensive Cancer Center At Aventura
Clinical Trials Ragisha Gopalakrishnan is currently running
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting
2 awards
Phase 3
40 criteria
Alpelisib + Tucatinib
for Breast Cancer
This trial tests a combination of two drugs, tucatinib and alpelisib, in patients with a specific type of advanced breast cancer. These patients have a genetic mutation and a type of cancer that may not respond well to standard treatments. The drugs work by blocking signals that help cancer cells grow. Alpelisib is approved for treating certain types of advanced breast cancer.
Recruiting
1 award
Phase 1 & 2
11 criteria
More about Ragisha Gopalakrishnan
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Ragisha Gopalakrishnan has experience with
- AlloStim
- Radiation Therapy
- Olaparib
- Alpelisib
- Tucatinib
- Decision Aid
Breakdown of trials Ragisha Gopalakrishnan has run
Breast Cancer
Colorectal Cancer
Lobular Carcinoma in Situ
Atypical Breast Hyperplasia
Perichondritis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ragisha Gopalakrishnan specialize in?
Ragisha Gopalakrishnan focuses on Breast Cancer and Colorectal Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are PR positive.
Is Ragisha Gopalakrishnan currently recruiting for clinical trials?
Yes, Ragisha Gopalakrishnan is currently recruiting for 2 clinical trials in Miami Beach Florida. If you're interested in participating, you should apply.
Are there any treatments that Ragisha Gopalakrishnan has studied deeply?
Yes, Ragisha Gopalakrishnan has studied treatments such as AlloStim, Radiation Therapy, Olaparib.
What is the best way to schedule an appointment with Ragisha Gopalakrishnan?
Apply for one of the trials that Ragisha Gopalakrishnan is conducting.
What is the office address of Ragisha Gopalakrishnan?
The office of Ragisha Gopalakrishnan is located at: Mount Sinai Medical Center, Miami Beach, Florida 33140 United States. This is the address for their practice at the Mount Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.